Please use this identifier to cite or link to this item:
|Title:||An unusual finding of massive pulmonary embolism in a patient during treatment with high-dose ibuprofen||Authors:||Bilora, Franca
|Keywords:||Adverse effects;Ibuprofen;Non-steroidal anti-inflammatory;Pulmonary embolism;Venous thromboembolism||Keywords Plus:||NONSTEROIDAL ANTIINFLAMMATORY DRUGS;METAANALYSIS||Mesh headings:||Heparin, Low-Molecular-Weight;Ibuprofen;Pulmonary Embolism||Secondary Mesh headings:||Aged;Anti-Inflammatory Agents, Non-Steroidal;Anticoagulants;Female;Humans;Long Term Adverse Effects;Osteoarthritis, Spine;Rivaroxaban;Tomography, Spiral Computed;Treatment Outcome||Issue Date:||Feb-2016||Publisher:||SPRINGER||Journal:||Aging clinical and experimental research||Abstract:||
Non-steroidal anti-inflammatory drugs have been associated with an increased risk of venous thromboembolism. We report for the first time, the case of a patient who developed massive pulmonary embolism after a long period of treatment with high doses of ibuprofen. A 65-year-old woman was admitted with severe dyspnea while on treatment with high doses of ibuprofen for diffuse spine pain due to arthrosis. A spiral computed tomography showed a massive pulmonary embolism. No other explanation for the thromboembolic disorder was found. She was successfully treated with therapeutic doses of low-molecular-weight heparin followed by rivaroxaban. Ibuprofen was discontinued and replaced by tramadol. High-dose ibuprofen is likely to have accounted for the life-threatening thromboembolic disorder.
|Appears in Collections:||Articles|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.